Republic of Korea vs Lebanon: Share of S. aureus infections resistant to methicillin
Republic of Korea
45.7%
in 2022
Lebanon
52.5%
in 2022
Republic of Korea rank
12th
Lebanon rank
10th
Share of S. aureus infections resistant to methicillin over time
- Republic of Korea
- Lebanon
How they compare
Lebanon currently reports 52.5% against 45.7% in Republic of Korea, a difference of 6.8%.
That makes Lebanon's figure about 1.1 times Republic of Korea's.
The two have swapped places 1 time across 6 shared years of data; in 2017 it was Republic of Korea ahead.
Republic of Korea ranks 12th and Lebanon ranks 10th of 45 countries.
Republic of Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Republic of Korea | Lebanon | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 49.7% | 17.8% | 31.9% | Republic of Korea |
| 2020s | 46.2% | 41.6% | 4.6% | Republic of Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of s. aureus infections resistant to methicillin, Republic of Korea or Lebanon?
- Lebanon, at 52.5% against 45.7% in Republic of Korea as of 2022.
- What is the difference in share of s. aureus infections resistant to methicillin between Republic of Korea and Lebanon?
- 6.8%, with Lebanon ahead.
- How many years of comparable data are there for Republic of Korea and Lebanon?
- 6 years are reported by both, from 2017 to 2022.
- How do Republic of Korea and Lebanon rank globally for share of s. aureus infections resistant to methicillin?
- Republic of Korea ranks 12th and Lebanon ranks 10th of 45 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of S. aureus infections resistant to methicillin. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%).